CNY 25.67
(-0.62%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 22.58 Billion CNY | 13.14% |
2022 | 19.88 Billion CNY | 29.75% |
2021 | 15.32 Billion CNY | 16.6% |
2020 | 13.14 Billion CNY | 27.91% |
2019 | 10.27 Billion CNY | 48.66% |
2018 | 6.91 Billion CNY | 43.79% |
2017 | 4.8 Billion CNY | 28.76% |
2016 | 3.73 Billion CNY | 31.21% |
2015 | 2.84 Billion CNY | 27.59% |
2014 | 2.23 Billion CNY | 23.61% |
2013 | 1.8 Billion CNY | 17.2% |
2012 | 1.53 Billion CNY | 25.76% |
2011 | 1.22 Billion CNY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 5.76 Billion CNY | -3.05% |
2024 Q3 | 5.43 Billion CNY | -5.74% |
2024 Q1 | 5.94 Billion CNY | -10.81% |
2023 Q2 | 5.44 Billion CNY | 3.31% |
2023 Q1 | 5.26 Billion CNY | -19.46% |
2023 FY | 22.49 Billion CNY | 13.14% |
2023 Q4 | 6.66 Billion CNY | 28.7% |
2023 Q3 | 5.18 Billion CNY | -4.76% |
2022 Q4 | 6.53 Billion CNY | 42.22% |
2022 Q3 | 4.59 Billion CNY | -0.09% |
2022 Q2 | 4.6 Billion CNY | 10.92% |
2022 Q1 | 4.14 Billion CNY | -5.47% |
2022 FY | 19.88 Billion CNY | 29.75% |
2021 Q2 | 3.71 Billion CNY | 2.39% |
2021 FY | 15.32 Billion CNY | 16.6% |
2021 Q1 | 3.62 Billion CNY | -2.11% |
2021 Q3 | 3.59 Billion CNY | -3.36% |
2021 Q4 | 4.38 Billion CNY | 22.18% |
2020 Q2 | 3.24 Billion CNY | 6.46% |
2020 Q3 | 3.14 Billion CNY | -3.12% |
2020 Q4 | 3.7 Billion CNY | 17.94% |
2020 FY | 13.14 Billion CNY | 27.91% |
2020 Q1 | 3.04 Billion CNY | 5.56% |
2019 Q4 | 2.88 Billion CNY | 23.37% |
2019 Q1 | 2.46 Billion CNY | 9.9% |
2019 FY | 10.27 Billion CNY | 48.66% |
2019 Q2 | 2.57 Billion CNY | 4.43% |
2019 Q3 | 2.34 Billion CNY | -9.24% |
2018 Q4 | 2.24 Billion CNY | 34.36% |
2018 FY | 6.91 Billion CNY | 43.79% |
2018 Q3 | 1.67 Billion CNY | 10.62% |
2018 Q2 | 1.51 Billion CNY | 2.03% |
2018 Q1 | 1.48 Billion CNY | 6.73% |
2017 FY | 4.8 Billion CNY | 28.76% |
2017 Q1 | 1.07 Billion CNY | 1.61% |
2017 Q2 | 1.16 Billion CNY | 7.61% |
2017 Q3 | 1.18 Billion CNY | 1.73% |
2017 Q4 | 1.38 Billion CNY | 17.61% |
2016 Q2 | 929.08 Million CNY | 11.46% |
2016 Q3 | 909.83 Million CNY | -2.07% |
2016 Q4 | 1.06 Billion CNY | 16.63% |
2016 FY | 3.73 Billion CNY | 31.21% |
2016 Q1 | 833.54 Million CNY | -3.86% |
2015 Q4 | 867.03 Million CNY | 28.33% |
2015 Q3 | 675.63 Million CNY | 1.86% |
2015 Q2 | 663.31 Million CNY | 3.72% |
2015 Q1 | 639.53 Million CNY | 0.47% |
2015 FY | 2.84 Billion CNY | 27.59% |
2014 Q1 | 496.38 Million CNY | 0.0% |
2014 FY | 2.23 Billion CNY | 23.61% |
2014 Q4 | 636.51 Million CNY | 15.24% |
2014 Q3 | 552.34 Million CNY | 1.35% |
2014 Q2 | 544.98 Million CNY | 9.79% |
2013 FY | 1.8 Billion CNY | 17.2% |
2012 FY | 1.53 Billion CNY | 25.76% |
2011 FY | 1.22 Billion CNY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Shanghai No.1 Pharmacy Co., Ltd. | 1.81 Billion CNY | -1141.441% |
Jointown Pharmaceutical Group Co., Ltd | 149.7 Billion CNY | 84.912% |
LBX Pharmacy Chain Joint Stock Company | 22.35 Billion CNY | -1.028% |
Yunnan Jianzhijia Health-Chain Co., Ltd. | 9.08 Billion CNY | -148.75% |